Bayer settles Roundup cancer claims with $7.25 billion
Statements (10 of 12)
- Neutral
Bayer is paying US$7.25 billion to resolve lawsuits over Roundup herbicide claims of cancer
- Neutral
Bayer received approval for a billion-euro comparison to Glyphosat in the US
- Bullish
US court rules in favor of Bayer in Glyphosate lawsuit settlement
- Bearish
Bayer pays $7.25 billion in claims related to Roundup, a herbicide product.
- Neutral
Bayer is settling over 7.25 billion dollars in claims against users of Roundup.
- Neutral
US courts have approved a billion-dollar settlement between Bayer and glyphosate plaintiffs in the United States.
- Neutral
The EU judge approved Bayer's $7.025 billion settlement agreement for Roundup herbicide cases.
- Neutral
Brazilian Tribunal approved a US$ 7.25 billion agreement with Bayer for a cancer trial linked to a herbicide
- Neutral
Bayer is paying $7.25 billion to settle cancer claims from 65,000 people alleging Roundup causes cancer.
- Bearish
Bayer will pay up to $7.25 billion over two decades to resolve cancer claims from U.S. patients regarding Roundup.
2 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=7d2a5a38-4d23-4b4a-902a-144942115862 Get a free API key ↗